Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease
1 other identifier
interventional
177
1 country
1
Brief Summary
Comparison of Circular(Soave)and Heart-shaped Anastomosis in Hirschsprung's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2014
CompletedFirst Posted
Study publicly available on registry
September 9, 2014
CompletedStudy Start
First participant enrolled
November 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedApril 28, 2026
April 1, 2026
3.9 years
August 27, 2014
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
bowel function score
Ability to control bowel movements, Feeling before bowel movement, Soiling, Defecation frequency, Constipation, Social problem
2 years
Secondary Outcomes (4)
rate of postoperative complication
1month/6 month/12 month/2 years
rate of reoperation
1month/6 month/12 month/2 years
rate of readmission
1month/6 month/12 month/2 years
bowel function score
1 month/6 month/12 month
Study Arms (2)
Heart-shaped anastomosis
EXPERIMENTALHeart shaped anastomosis
Circle anastomosis
ACTIVE COMPARATORSoave anastomosis
Interventions
a new operation approach for Hirschsprung disease
Eligibility Criteria
You may qualify if:
- Age\<14 years
- Hirschsprung's disease diagnosed by biopsy
- Surgical indication
You may not qualify if:
- Age\>14 years
- Not Hirschsprung's disease
- Surgical contraindication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tongji Hospitallead
Study Sites (1)
Tongji Hospital
Wuhan, Hubei, 430030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiexiong Feng, MD.
Department of Pediatric surgery, Tongji hospital, HUST, Wuhan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 27, 2014
First Posted
September 9, 2014
Study Start
November 30, 2019
Primary Completion
October 30, 2023
Study Completion
October 30, 2025
Last Updated
April 28, 2026
Record last verified: 2026-04